Deprescription: The prescription metabolism
- 1*
- 1Department of Pharmacology, Indira Gandhi Medical College and Research Institute, Puducherry, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Gurusamy Sivagnanam
Department of Pharmacology, Indira Gandhi Medical College and Research Institute, Puducherry, India.
Email: drsivagnanam@gmail.com
Copyright: © 2016 The Author(s). This is an open access article.
Published: Jan 1, 2016, Received: Apr 7, 2016, Accepted: Jul 15, 2016
Abstract
Deprescribing is a structured approach to drug discontinuation. An alternative suggested term is “prescription metabolism.” The major aim of deprescription is to purge the drug(s) considered unwanted in a given patient, especially in the elderly patients with multiple comorbidities or in those suffering from chronic disease. Like drug metabolism, prescription metabolism is a way of eliminating unwanted, troublesome, or cost‑ineffective medications. The removal of such drugs has been found to decrease the incidence of adverse drug reactions and improves the rate of medication adherence, thereby reducing the economic burden on the patient as well as on the health care providers. Certain categories of drugs are to be tapered rather than abruptly stopped. Despite the availability of many tools to minimize drug therapy‑related problems, there is little guidance for the process of deprescribing in general clinical practice. Various methods to reduce the risks of polypharmacy include patient education, physician education, and regulatory intervention. The suggested S and S approach (seek and screen, save and severe, sensitize and supervise) may be tried for deprescribing in general practice. More research on deprescribing is the need of the hour in almost all branches of clinical medicine which may pave the way for the betterment of health care.
Keywords
Recommended articles
- Mirtazapine withdrawal‑induced mania
Jitendra Kumar Verma, Satyakam Mohapatra · Journal of Pharmacology and Pharmacotherapeutics
- Catatonia in mixed alcohol and benzodiazepine withdrawal
Aniruddha Basu, Amit Jagtiani, Rajiv Gupta · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026